Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 07
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+4.73%
|
$598,500
$399.66 P/Share
|
|
Apr 06
2022
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
302
-0.24%
|
-
|
|
Apr 06
2022
|
Leonard S Schleifer President & CEO |
SELL
Open market or private sale
|
Indirect |
2,653
-19.18%
|
$1,883,630
$710.04 P/Share
|
|
Apr 05
2022
|
Leonard S Schleifer President & CEO |
SELL
Open market or private sale
|
Indirect |
4,461
-24.39%
|
$3,167,310
$710.05 P/Share
|
|
Apr 01
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$69,300
$693.17 P/Share
|
|
Apr 01
2022
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
5,114
-1.38%
|
$3,538,888
$692.65 P/Share
|
|
Apr 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.84%
|
$701,000
$701.82 P/Share
|
|
Apr 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.62%
|
$342,000
$342.93 P/Share
|
|
Apr 01
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
316
-0.54%
|
$220,568
$698.74 P/Share
|
|
Mar 31
2022
|
Leonard S Schleifer President & CEO |
SELL
Open market or private sale
|
Indirect |
2,886
-13.63%
|
$2,049,060
$710.01 P/Share
|
|
Mar 31
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,184
-3.91%
|
$828,800
$700.99 P/Share
|
|
Mar 31
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+4.73%
|
$598,500
$399.66 P/Share
|
|
Mar 31
2022
|
Christopher R. Fenimore VP Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
8,654
-14.68%
|
$6,057,800
$700.99 P/Share
|
|
Mar 31
2022
|
Christopher R. Fenimore VP Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+15.94%
|
$4,956,000
$413.05 P/Share
|
|
Mar 30
2022
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
1,240
-53.4%
|
$868,000
$700.0 P/Share
|
|
Mar 30
2022
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,240
+34.81%
|
$471,200
$380.95 P/Share
|
|
Mar 30
2022
|
P Roy Vagelos Director |
SELL
Open market or private sale
|
Indirect |
28,572
-23.98%
|
$20,000,400
$700.01 P/Share
|
|
Mar 30
2022
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
2,431
-28.56%
|
$1,701,700
$700.0 P/Share
|
|
Mar 30
2022
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,431
+22.21%
|
$909,194
$374.12 P/Share
|
|
Mar 30
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
408
-27.38%
|
$285,192
$699.0 P/Share
|
|
Mar 30
2022
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
408
+21.5%
|
$152,592
$374.12 P/Share
|
|
Mar 29
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
1,522
-58.45%
|
$1,063,878
$699.0 P/Share
|
|
Mar 29
2022
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,522
+36.89%
|
$569,228
$374.12 P/Share
|
|
Mar 29
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
2,683
-0.63%
|
$1,845,904
$688.04 P/Share
|
|
Mar 28
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
11,817
-7.16%
|
$8,094,645
$685.26 P/Share
|
|
Mar 28
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,500
+7.94%
|
$6,699,000
$462.06 P/Share
|
|
Mar 21
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
7,439
-76.63%
|
$5,132,910
$690.0 P/Share
|
|
Mar 21
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,439
+43.38%
|
$2,826,820
$380.95 P/Share
|
|
Mar 21
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
312
-1.07%
|
$215,592
$691.31 P/Share
|
|
Mar 21
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
400
+1.36%
|
$152,400
$381.92 P/Share
|
|
Mar 21
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
300
-1.04%
|
$207,900
$693.0 P/Share
|
|
Mar 17
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
7,830
-77.53%
|
$5,324,400
$680.0 P/Share
|
|
Mar 17
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+43.67%
|
$2,944,080
$376.69 P/Share
|
|
Mar 17
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
286
-0.98%
|
$195,052
$682.5 P/Share
|
|
Mar 17
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
365
+1.23%
|
$139,065
$381.92 P/Share
|
|
Mar 17
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
83
-0.29%
|
$56,938
$686.0 P/Share
|
|
Mar 16
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
4,361
-65.78%
|
$2,943,675
$675.0 P/Share
|
|
Mar 16
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,361
+39.68%
|
$1,631,014
$374.12 P/Share
|
|
Mar 16
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
300
-1.03%
|
$203,100
$677.0 P/Share
|
|
Mar 16
2022
|
Huda Y Zoghbi Director |
SELL
Open market or private sale
|
Direct |
2,000
-64.89%
|
$1,350,000
$675.0 P/Share
|
|
Mar 16
2022
|
Huda Y Zoghbi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+39.35%
|
$782,000
$391.92 P/Share
|
|
Mar 14
2022
|
P Roy Vagelos Director |
SELL
Payment of exercise price or tax liability
|
Direct |
48,103
-12.22%
|
$31,507,465
$655.29 P/Share
|
|
Mar 14
2022
|
P Roy Vagelos Director |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+16.0%
|
$13,425,000
$179.13 P/Share
|
|
Mar 01
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-4.84%
|
$615,000
$615.39 P/Share
|
|
Mar 01
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+4.62%
|
$342,000
$342.93 P/Share
|
|
Mar 01
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$61,500
$615.47 P/Share
|
|
Feb 28
2022
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
2,000
-3.63%
|
$1,230,000
$615.5 P/Share
|
|
Feb 25
2022
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
2,000
-6.66%
|
$1,242,000
$621.0 P/Share
|
|
Feb 23
2022
|
Michael S Brown Director |
SELL
Open market or private sale
|
Indirect |
500
-6.53%
|
$304,000
$608.68 P/Share
|
|
Feb 23
2022
|
Daniel P Van Plew EVP & General Mgr Industrial O |
SELL
Open market or private sale
|
Direct |
6,781
-1.8%
|
$4,149,972
$612.92 P/Share
|